The evidence was based on experimental data only briefly described in the patent and included models of: gastric ulcers, heart damage, liver damage, pancreatic injury, kidney damage, experimental diabetes, fever, edema, rhinitis, bone fracture, burns, skin wounds, hypersensitivity reactions, pupil dilation, colon injury, tumour growth, radiation injury, red blood cell development, fertility and lactation, tooth damage, several types of central and peripheral nerve damage, and survival from infection with Trichinosis (i.e., tapeworms) as well as several viruses
Beyond cosmetics, research has explored GHK-Cu's potential in therapeutic wound healing (chronic wounds, surgical recovery, diabetic ulcers), hair restoration, tissue engineering, nerve regeneration, lung disease, and even systemic anti-aging interventions
About Epithalon Research Epithalon is a synthetic tetrapeptide investigated in published scientific literature involving peptide biology, telomere biology, cellular aging research models, molecular signaling pathways, gene expression studies, and experimental peptide pharmacology
Personal use for research purposes occupies a different regulatory space than commercial distribution for therapeutic claims
